Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 8/12/2022 | $6.00 → $2.00 | Outperform → Neutral | Robert W. Baird |
| 3/9/2022 | $20.00 → $10.00 | Outperform | Northland Capital Markets |
| 3/9/2022 | $6.00 → $5.00 | Neutral | B of A Securities |
| 3/9/2022 | $15.00 → $8.00 | Buy | Needham |
| 12/22/2021 | $14.00 → $6.00 | Buy → Neutral | B of A Securities |
| 9/17/2021 | $14.00 | Buy | B of A Securities |
| 9/9/2021 | $22.00 | Outperform | Cowen |
| 9/7/2021 | $15.00 | Buy | Needham |
Additional capital raised through private placement Reduction in headcount and operating costs targets lower cash burn Advanced blood pressure biomarker by demonstrating promising intra-subject tracking against standard blood pressure cuff Rockley Photonics Holdings Limited (NYSE:RKLY), a global medical technology company focused on delivering leading edge silicon photonics-based biosensing solutions by targeting a portfolio of biomarkers, today announced its financial results for the third quarter ended September 30, 2022. During the quarter, the Company advanced its technology platform, Bioptx™, through several technical and clinical targets: Expanded Free-Living Human Study of Its B
Rockley Photonics (NYSE:RKLY), a global leader in photonics-based health monitoring and communications solutions, today announced that it plans to report its third quarter 2022 financial results after the market closes on Wednesday, November 9, 2022. The company also plans to host a conference call that day at 5:00 p.m. Eastern Time to review its financial results and business outlook. The conference call can be accessed by dialing 877-407-0832 from the United States or +1 201-689-8433 internationally, referencing Rockley Photonics. A live webcast and replay of the conference call can be accessed from the investor relations page on Rockley's website at investors.rockleyphotonics.com. Follo
Signs Supply Agreement and Receives First Commercial Purchase Order from Top-Tier Medtech Company for Bioptx™ Baseline Band, Targets Fourth Quarter to Begin Shipping Signs First Contract Research Organization Partnership to Develop and Evaluate Rockley's Bioptx™ Biomarker Sensing Platform for Use in Clinical Trials Bolsters Board of Directors and Establishes Scientific Advisory Board Rockley Photonics Holdings Limited (NYSE:RKLY), a global leader in photonics-based health monitoring and communications solutions, today announced its financial results for the second quarter ended June 30, 2022. "I am proud of the progress we made in the second quarter. As we ramp towards commercial produc
15-12G - Rockley Photonics Holdings Ltd (0001852117) (Filer)
10-K - Rockley Photonics Holdings Ltd (0001852117) (Filer)
8-K - Rockley Photonics Holdings Ltd (0001852117) (Filer)
On January 23, 2023 (the "Petition Date"), Rockley Photonics Holdings Limited (the "Company" or "Rockley"), filed a voluntary petition for relief under chapter 11 of title 11 (the "Chapter 11 Case") of the United States Code (the "Bankruptcy Code") in the United States Bankruptcy Court for the Southern District of New York (the "Bankruptcy Court"). The Company filed motions with the Bankruptcy Court to seek authorization to continue to operate its business as a "debtor in possession" under the jurisdiction of the Bankruptcy Court and in accordance with the applicable provisions of the Bankruptcy Code and the orders of the Bankruptcy Court. The Company has filed a series of first day motions
Gainers WiSA Technologies (NASDAQ:WISA) stock moved upwards by 40.1% to $0.17 during Friday's pre-market session. The market value of their outstanding shares is at $12.3 million. Mawson Infra Gr (NASDAQ:MIGI) shares moved upwards by 15.85% to $0.44. The company's market cap stands at $36.3 million. Minim (NASDAQ:MINM) shares rose 11.44% to $0.22. The company's market cap stands at $10.3 million. ACM Research (NASDAQ:ACMR) shares moved upwards by 7.2% to $11.16. The market value of their outstanding shares is at $663.5 million. Avaya Hldgs (NYSE:AVYA) shares moved upwards by 6.47% to $0.25. The company's market cap stands at $22.1 million. PagerDuty (NYSE:PD) shares increased by 6.1% t
Robert W. Baird downgraded Rockley Photonics from Outperform to Neutral and set a new price target of $2.00 from $6.00 previously
Northland Capital Markets reiterated coverage of Rockley Photonics Hldgs with a rating of Outperform and set a new price target of $10.00 from $20.00 previously
B of A Securities reiterated coverage of Rockley Photonics Hldgs with a rating of Neutral and set a new price target of $5.00 from $6.00 previously
4 - Rockley Photonics Holdings Ltd (0001852117) (Issuer)
3 - Rockley Photonics Holdings Ltd (0001852117) (Issuer)
4 - Rockley Photonics Holdings Ltd (0001852117) (Issuer)
SC 13G/A - Rockley Photonics Holdings Ltd (0001852117) (Subject)
SC 13G - Rockley Photonics Holdings Ltd (0001852117) (Subject)
SC 13G - Rockley Photonics Holdings Ltd (0001852117) (Subject)
Rockley Photonics Holdings Limited (NYSE:RKLY) ("Rockley"), a global medical technology company focused on delivering leading edge silicon photonics-based biosensing solutions by targeting a portfolio of biomarkers, today announced that it received 12.9 million pounds sterling ($15.5 million) for its fiscal 2020 R&D tax credit from HMRC, the tax agency of the UK government. The Company filed its fiscal 2021 R&D tax credit application and expects to file its fiscal 2022 R&D tax credit application in 2023. About Rockley Photonics Formed in 2013, Rockley is a global medical technology company focused on delivering leading edge silicon photonics-based biosensing solutions that target a portfo
Rockley Photonics Holdings Limited (NYSE:RKLY) ("Rockley"), a global medical technology company focused on delivering leading edge silicon photonics-based biosensing solutions by targeting a portfolio of biomarkers, today announced that it received a notice from the New York Stock Exchange ("NYSE") on December 9, 2022, indicating that the Company is not in compliance with NYSE's continued listing standards, which require an average market capitalization of not less than $50 million over a 30 trading-day period and stockholders' equity of not less than $50 million. The notice has no immediate impact on the listing of Rockley's common stock on the NYSE, subject to the Company's compliance wit
Rickman to serve as executive chair; Becker promoted to interim chief financial officer Rockley Photonics Holdings Limited (NYSE:RKLY), a global medical technology company focused on delivering leading edge silicon photonics-based biosensing solutions by targeting a portfolio of biomarkers, today announced changes to its senior management team. These changes are intended to position the Company for its next phase of growth. Effective immediately, Richard A. Meier has been appointed president and chief executive officer, and will join the board of directors. Dr. Andrew Rickman has resigned as chief executive officer and will take on the role of executive chairman of Rockley. Chad Becker wi
Meier to focus on driving cash-efficient performance and enabling commercial production ramp Rockley Photonics Holdings Limited (NYSE:RKLY) ("Rockley"), a global leader in photonics-based health monitoring and communications solutions, today announced the appointment of Richard A. "Randy" Meier as president and chief financial officer (CFO), effective immediately. Meier will shape Rockley's financial and commercialization strategies, and lead its finance, supply chain, quality, regulatory and compliance functions. An accomplished finance and operations leader with a rich background in healthcare therapeutics and medical devices, Meier joins Rockley from Intersect ENT, a leading global ear
Rockley Photonics (NYSE:RKLY), a global leader in photonics-based health monitoring and communications solutions, today announced that it named Nicolaus Henke to its board of directors. Dr. Henke will join the board as an independent director, effective February 16, 2022, and will serve on the Nominating & Corporate Governance Committee. "I am very pleased with the appointment of Nicolaus Henke to our board. He brings a wealth of practical experience which will have an immediate impact on Rockley," said Dr. Andrew Rickman, chairman and chief executive officer of Rockley Photonics. "Throughout his career, Nico has advised top teams in leading health systems, medical device companies and pha
Julien Mininberg, Jaymin Patel and Pamela Puryear, Ph.D., Bring Significant Technology, Distribution, Consumer Brand and Human Resources Expertise Food solutions company SpartanNash (the "Company") (NASDAQ:SPTN) today announced that, following a comprehensive board refreshment process, three new independent directors, Julien Mininberg, Jaymin Patel and Pamela Puryear, Ph.D., have been appointed to the Company's Board of Directors (the "Board"), effective immediately. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220207005303/en/Julien Mininberg (Photo: Business Wire) "Since last summer, our Board has undertaken a deliberate and